FDA Inspection
Sterling Knight Pharmaceuticals, LLCSterling Knight Pharmaceuticals, LLC – FDA Inspection, Apr 11, 2019
Record Details
This FDA Inspection record concerns Sterling Knight Pharmaceuticals, LLC, with an inspection on April 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 886d47b4-7bdc-43cc-ae06-274a4209e7ca
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085950
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.22(a)Lack of quality control unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sterling Knight Pharmaceuticals, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 17, 2015 | NAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
Other documents for Sterling Knight Pharmaceuticals, LLC
- FDA Inspection 949854 - 2015-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.